Re-evaluation of healthcare sector throws up the growth in the industry and opportunities and threats that remain.
Twelve months after the first ranking of the most influential corporate venturing units in the healthcare sector and it has been a busy year for the industry.
The pressures to use an acquisitions strategy to fill gaps in a portfolio or as a way to step back from an impending patents cliff when blockbuster drugs face generic competition remain.
This can cause turmoil in corporate venturing and other longer-term innovation strategies. Cephalon’s decision to set up a ventures…
